These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8633594)

  • 1. The galactose elimination capacity test: a study of the technique based on the analysis of 868 measurements.
    Fabbri A; Bianchi G; Motta E; Brizi M; Zoli M; Marchesini G
    Am J Gastroenterol; 1996 May; 91(5):991-6. PubMed ID: 8633594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
    Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
    Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of galactose eliminating capacity after intravenous administration--a liver function test].
    Kupcová V; Turecký L; Brixová E
    Vnitr Lek; 1992 Oct; 38(10):992-9. PubMed ID: 1481380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model.
    Reichen J; Widmer T; Cotting J
    Hepatology; 1991 Sep; 14(3):504-10. PubMed ID: 1874495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death.
    Merkel C; Marchesini G; Fabbri A; Bianco S; Bianchi G; Enzo E; Sacerdoti D; Zoli M; Gatta A
    Hepatology; 1996 Oct; 24(4):820-3. PubMed ID: 8855183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
    Grimm L; Bircher J; Preisig R
    Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic value of the serial determination of galactose elimination capacity in chronic active hepatitis].
    Aebli N; Reichen J
    Schweiz Med Wochenschr; 1991 Jun; 121(26):970-6. PubMed ID: 1862313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncertainty in liver function assessment on the basis of single-point galactose concentration.
    Fabbri A; Bianchi G; Brizi M; Zoli M; Marchesini G
    Digestion; 1997; 58(4):379-83. PubMed ID: 9324166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
    Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B
    Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous loading with galactose as a liver function test. Methods and clinical value].
    Kuntz HD; Kuntz E
    Fortschr Med; 1983 Jun; 101(21):999-1004. PubMed ID: 6873856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous galactose overload as a test of hepatic function].
    Vivancos J; Font J; Carbonell J; Prellezo P; Balcells A
    Rev Clin Esp; 1978 Aug; 150(3-4):125-8. PubMed ID: 715269
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats.
    Young TH; Tang HS; Lee HS; Hsiong CH; Hu OY
    Metabolism; 2007 Sep; 56(9):1265-9. PubMed ID: 17697871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver.
    Ballmer PE; Reichen J; McNurlan MA; Sterchi AB; Anderson SE; Garlick PJ
    Hepatology; 1996 Jul; 24(1):53-9. PubMed ID: 8707282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intravenous and peroral galactose elimination tests with and without ethanol in different clinical conditions.
    Kesäniemi YA; Kurppa KO; Salaspuro MP
    Scand J Gastroenterol; 1973; 8(7):593-8. PubMed ID: 4768306
    [No Abstract]   [Full Text] [Related]  

  • 18. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms.
    Shoemaker RC; House DE
    Neurotoxicol Teratol; 2006; 28(5):573-88. PubMed ID: 17010568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining empirically based self-reported cognitive change: development of reliable change indices and standardized regression-based change norms for the multiple abilities self-report questionnaire in an epilepsy sample.
    Martin R; Griffith HR; Sawrie S; Knowlton R; Faught E
    Epilepsy Behav; 2006 Feb; 8(1):239-45. PubMed ID: 16368275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the hepatic elimination capacity (Lm) of galactose by single injection.
    Tygstrup N
    Scand J Clin Lab Invest Suppl; 1966; 18():118-25. PubMed ID: 5958511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.